Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Central vision can fade slowly with age-related macular degeneration. Faces blur. Words smear on a page. A dark spot can sit ...

GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

Medically reviewed by Christine L. Larsen, MD Key Takeaways Macular degeneration is a common eye disease, affecting more than 19 million people in the United States alone.The condition can reduce a ...

An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...

Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...

People with macular degeneration and other forms of central vision loss can see details like text and faces with this device.

Ask a clinical question and tap into Healio AI's knowledge base. Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity ...

Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells (hESCs) appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt ...

Anybody who caught Stevie Nicks’ two sets on “Saturday Night Live” in October — during which she performed her brand-new female empowerment anthem “The Lighthouse” as well as her classic “Edge of ...